Ignite Creation Date:
2024-10-26 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06566755
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-21
Brief Title:
Cadonilimab AK104 Combined With Chemotherapy and Bevacizumab as First-line Treatment for RAS Mutated or Right Sided-metastatic MSS Colorectal Cancer
Sponsor:
Organization:
None